Cresco Labs | Jotup

Cresco Labs Reports Continued Trend of Financial Improvement with First Quarter 2024 Financial Results

Retrieved on:

星期三, 五月 15, 2024

First quarter Adjusted EBITDA1 of $53 million, up 82% year-over-year; and Adjusted EBITDA margin1 of 29%, a 1,380 bps improvement.

Key Points:

First quarter Adjusted EBITDA1 of $53 million, up 82% year-over-year; and Adjusted EBITDA margin1 of 29%, a 1,380 bps improvement.
See “Non-GAAP Financial Measures” at the end of this press release for more information regarding the Company’s use of non-GAAP financial measures.
The financial information reported in this press release is based on unaudited management prepared financial statements for the quarter ended March 31, 2024.
This release reports its financial results in accordance with U.S. GAAP and includes certain non-GAAP financial measures that do not have standardized definitions under U.S. GAAP.

SUNNYSIDE CANNABIS WORKERS IN RIVER NORTH JOIN TEAMSTERS

Retrieved on:

星期三, 五月 1, 2024

Local, International Brotherhood of Teamsters, News, Cresco Labs

CHICAGO, May 1, 2024 /PRNewswire/ -- Workers at Sunnyside, a subsidiary of Cresco Labs, in River North have voted overwhelmingly to join Teamsters Local 777.

Key Points:

CHICAGO, May 1, 2024 /PRNewswire/ -- Workers at Sunnyside, a subsidiary of Cresco Labs, in River North have voted overwhelmingly to join Teamsters Local 777.
"We are thrilled to welcome another Cresco location to Teamsters Local 777," said Jim Glimco, President of Local 777.
"Dispensary workers are seeing their counterparts at other locations organize with the Teamsters and they want to secure the benefits of a union contract for themselves.
We look forward to helping these workers get their first contract and continuing to organize workers in the cannabis industry across Illinois."

EQS-News: BIRKENSTOCK ANNOUNCES MEGAN KULICK AS DIRECTOR INVESTOR RELATIONS

Retrieved on:

星期五, 五月 3, 2024

Telecommunications, University, JPMorgan Chase, Equity, Language, Nature, Zeitgeist, Geography, Telephone, Merrill (company), Business administration, Research, Foot, PIMCO, Senior, Street, MBA, Walking, Cresco Labs

LONDON, UNITED KINGDOM || APRIL 16, 2024

Key Points:

LONDON, UNITED KINGDOM || APRIL 16, 2024
Birkenstock Holding plc (“BIRKENSTOCK” or the “Company”, NYSE: BIRK), announced today the appointment of Megan Kulick to Director Investor Relations, effective April 15, 2024.
Based in New York, Ms. Kulick will report to the Board of Directors of the Company.
Birkenstock Holding plc is the ultimate parent company of Birkenstock Group B.V. & Co. KG and its subsidiaries (the "Birkenstock Group").
BIRKENSTOCK is the inventor of the footbed and has shaped the principle of walking as intended by nature ("Naturgewolltes Gehen").

Cresco Labs to Report First Quarter 2024 Financial Results on May 15, 2024

Retrieved on:

星期二, 四月 30, 2024

Cannabis, Natural Resources, Webcast, Cresco Labs

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the first quarter ended March 31st, 2024 on Wednesday, May 15th, 2024 before the market opens.

Key Points:

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the first quarter ended March 31st, 2024 on Wednesday, May 15th, 2024 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.
Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.

Cresco Labs Reports Fourth Quarter & Full Year 2023 Financial Results Demonstrating Significant Profitability and Cash Flow Improvements

Retrieved on:

星期三, 三月 13, 2024

Alternative Medicine, Cannabis, Retail, Health, Tobacco, Natural Resources, Specialty, Hierarchy, Tax, Webcast, EDGAR, Bank statement, Cresco Labs, GAAP, Depreciation, Eastern Time Zone, Core, Total, Video game

Fourth quarter revenue of $188 million, excluding the impact from strategic divestitures aimed to drive profitability, down 2% year-over-year.

Key Points:

Fourth quarter revenue of $188 million, excluding the impact from strategic divestitures aimed to drive profitability, down 2% year-over-year.
Fourth quarter adjusted EBITDA1 nearly doubled year-over-year to $55 million, or 29% of revenue, a 1,400 bps improvement.
1 See “Non-GAAP Financial Measures” at the end of this press release for more information regarding the Company’s use of non-GAAP financial measures.
As of December 31, 2023, current assets were $278 million, including cash, cash equivalents and restricted cash of $109 million.

Cresco Labs Continues Retail Expansion in Pennsylvania with New Gettysburg Store

Retrieved on:

星期五, 二月 23, 2024

Cannabis, Alternative Medicine, Natural Resources, Health, Other Natural Resources, Caregiver, Multimedia, Commonwealth, Good news, Cresco Labs, Patient, Gettysburg Battlefield Historic District

The new store is located at 1380 York Rd., #300, just off US Route 15 and 10 minutes away from the Gettysburg Battlefield Historic District.

Key Points:

The new store is located at 1380 York Rd., #300, just off US Route 15 and 10 minutes away from the Gettysburg Battlefield Historic District.
Today’s opening brings Cresco Labs’ store count to 15 dispensaries in Pennsylvania and 72 locations nationally.
View the full release here: https://www.businesswire.com/news/home/20240223814577/en/
Cresco Labs opened a new Pennsylvania store in Gettysburg at 1380 York Rd., #300.
(Photo: Business Wire)
“We’re delighted to bring Sunnyside to the historic town of Gettysburg and the Gettysburg National Military Park that averages 1 million visitors annually,” said Charlie Bachtell, CEO and Co-founder of Cresco Labs.

Cresco Labs Promotes Greg Butler to President

Retrieved on:

星期四, 二月 1, 2024

Alternative Medicine, Cannabis, Retail, Health, Tobacco, Natural Resources, Specialty, Multimedia, Heart, Cresco Labs, Strategic planning, Marketing, Butler, Professionalization, Drug

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products and the operator of Sunnyside* dispensaries, is pleased to announce the promotion of Greg Butler to the position of President.

Key Points:

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products and the operator of Sunnyside* dispensaries, is pleased to announce the promotion of Greg Butler to the position of President.
Butler joined Cresco Labs in 2020 as Chief Commercial Officer and has advised the company since 2018.
Prior to Cresco Labs, Butler had over two decades of experience leading large iconic and insurgent brands for both large Fortune 500 and smaller privately owned businesses.
“I’m honored and incredibly excited to work alongside Charlie and the Cresco Labs team to evolve and accelerate our growth story,” said Greg Butler.

National Cannabis Roundtable Releases Inaugural Corporate Social Responsibility Report

Retrieved on:

星期三, 十二月 13, 2023

WASHINGTON, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Today, the National Cannabis Roundtable (NCR) is proud to announce the release of its inaugural Corporate Social Responsibility (CSR) report for 2022-2023 , titled: “ Better Tomorrow Than Today .” This comprehensive report highlights the collective efforts of NCR and its member companies to create positive impact in the cannabis industry and the communities they serve in the areas of criminal justice reform, equity in business opportunity, workforce utilization, and health disparities.

Key Points:

WASHINGTON, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Today, the National Cannabis Roundtable (NCR) is proud to announce the release of its inaugural Corporate Social Responsibility (CSR) report for 2022-2023 , titled: “ Better Tomorrow Than Today .” This comprehensive report highlights the collective efforts of NCR and its member companies to create positive impact in the cannabis industry and the communities they serve in the areas of criminal justice reform, equity in business opportunity, workforce utilization, and health disparities.
"We named this report ‘Better Tomorrow Than Today’ to not only celebrate the great work of our members, but to serve as an acknowledgment of the existing gaps within the U.S. cannabis market and our concentrated efforts to address these challenges,” said Saphira Galoob, Executive Director of the National Cannabis Roundtable.
“Looking ahead, we will continue to create initiatives and programs to contribute to the overall growth of the industry.
Verano: Launched its Round Up for Cannabis Reform dispensary donation program benefitting The Weldon Project’s MISSION [GREEN] and the non-profit organization’s advocacy for cannabis- related criminal justice reform.

Cresco Labs Reports Third Quarter 2023 Financial Results

Retrieved on:

星期三, 十一月 15, 2023

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the third quarter ended September 30, 2023.

Key Points:

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the third quarter ended September 30, 2023.
The financial information reported in this press release is based on unaudited management prepared financial statements for the quarter ended September 30, 2023.
The Company expects to file its unaudited condensed interim consolidated financial statements for the quarter ended September 30, 2023, on SEDAR+ on or about November 15, 2023.
Cresco Labs references certain non-GAAP financial measures throughout this press release, which may not be comparable to similar measures presented by other issuers.

Cresco Labs Commends Ohioans on Legalizing Adult-Use Cannabis

Retrieved on:

星期三, 十一月 8, 2023

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today issued a statement on behalf of its CEO Charles Bachtell following over 56 percent of Ohioans voting to pass adult-use cannabis legalization through state ballot measure.

Key Points:

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today issued a statement on behalf of its CEO Charles Bachtell following over 56 percent of Ohioans voting to pass adult-use cannabis legalization through state ballot measure.
Ohio represents the 24th state to end cannabis prohibition for adults 21 and over and the 15th state to legalize adult-use cannabis by election.
View the full release here: https://www.businesswire.com/news/home/20231107756443/en/
Cresco Labs applauds cannabis legalization in Ohio.
Cresco Labs operates a 50,000 square foot cultivation and processing facility in Yellow Springs that distributes its industry-leading cannabis brands to approximately 60 percent of Ohio’s 111 operating medical dispensaries.